Position in EWTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$217,370,500
+$48,845,500 QoQ
Shares Held
5,350,000
0.0% QoQ
Ownership
4.93%
of shares outstanding
% of Portfolio
12.67%
of 13F equity value
Holder Rank
#7
of 225 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EWTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NOVO HOLDINGS A/S holds $1,241,938,796 across 18 Biotechnology names. EWTX ranks #1 (17.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
This page
|
5,350,000 | $217,370,500 | |
| 2 | COAG |
Hemab Therapeutics Holdings, Inc.
|
4,180,550 | $153,551,601 | |
| 3 | MPLT |
MapLight Therapeutics, Inc.
|
3,686,622 | $132,128,532 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,125,000 | $131,703,750 | |
| 5 | AVLN |
Avalyn Pharma Inc.
|
3,883,289 | $127,837,873 | |
| 6 | AVBP |
ArriVent BioPharma, Inc.
|
1,500,000 | $52,110,000 | |
| 7 | ELVN |
Enliven Therapeutics, Inc.
|
1,000,000 | $50,750,000 | |
| 8 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,320,000 | $49,394,400 |
All Filings in EWTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $217,370,500 | 5,350,000 | Shares | Sole | 2026-08-14 | |
| 2026-04-23 | $167,080,500 | 5,350,000 | Shares | Sole | 2026-04-27 | |
| 2026-03-31 | $168,525,000 | 5,350,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $132,760,250 | 5,350,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $86,777,000 | 5,350,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $70,138,500 | 5,350,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $117,700,000 | 5,350,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $133,500,000 | 5,000,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $148,126,831 | 5,549,900 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $114,263,184 | 6,344,430 | Shares | Sole | 2024-08-20 | |
| 2023-12-31 | $66,424,430 | 6,071,703 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $34,790,858 | 6,071,703 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $47,055,698 | 6,071,703 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $40,498,259 | 6,071,703 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $54,281,024 | 6,071,703 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $59,745,557 | 6,071,703 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $44,474,167 | 5,587,207 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $54,195,907 | 5,587,207 | Shares | Sole | 2022-05-27 | |
| 2021-12-31 | $85,372,522 | 5,587,207 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $92,747,636 | 5,587,207 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $119,175,125 | 5,587,207 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $181,584,227 | 5,587,207 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||